Pertuzumab in Combination with Trastuzumab and Docetaxel in the Neoadjuvant Treatment for HER2-Positive Breast Cancer

INTRODUCTION: This study aims to assess safety and effectiveness of pertuzumab in combination with trastuzumab and docetaxel in the neoadjuvant treatment (NeoT) of HER2-positive breast cancer. METHODS: Two consecutive retrospective cohorts (n = 94, 2012–2015 and 2015–2017) of adult women with HER2-p...

Descripción completa

Detalles Bibliográficos
Autores principales: Vieira, Cláudia, Borges, Andreia, Pereira, Filipa F., Antunes, Pedro, Redondo, Patrícia, Antunes, Luís, Lopes, José M., Gonçalves, Francisco R., Borges, Marina, Bento, Maria J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Innovative Healthcare Institute 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888519/
https://www.ncbi.nlm.nih.gov/pubmed/36751658
http://dx.doi.org/10.36401/JIPO-22-12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888519/
https://www.ncbi.nlm.nih.gov/pubmed/36751658
http://dx.doi.org/10.36401/JIPO-22-12

Ejemplares similares